Teacher Retirement System of Texas Invests $1.14 Million in Envista Holdings Co. (NYSE:NVST)

Teacher Retirement System of Texas bought a new stake in Envista Holdings Co. (NYSE:NVST) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 58,969 shares of the company’s stock, valued at approximately $1,138,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Cerity Partners LLC increased its stake in Envista by 40.1% in the third quarter. Cerity Partners LLC now owns 37,995 shares of the company’s stock valued at $751,000 after purchasing an additional 10,883 shares during the period. Daiwa Securities Group Inc. grew its holdings in shares of Envista by 24.8% during the third quarter. Daiwa Securities Group Inc. now owns 53,332 shares of the company’s stock worth $1,054,000 after buying an additional 10,600 shares during the last quarter. Glenmede Trust Co. NA acquired a new position in Envista in the 3rd quarter valued at about $217,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Envista by 0.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 425,502 shares of the company’s stock valued at $8,408,000 after acquiring an additional 3,199 shares during the last quarter. Finally, PEAK6 Investments LLC acquired a new stake in Envista during the 3rd quarter worth approximately $1,144,000.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on NVST. UBS Group cut their price target on Envista from $23.00 to $21.00 and set a “neutral” rating for the company in a research note on Monday, March 10th. Piper Sandler raised their target price on shares of Envista from $17.00 to $18.00 and gave the stock a “neutral” rating in a research note on Monday, February 3rd. Mizuho assumed coverage on shares of Envista in a research note on Wednesday, December 4th. They set an “underperform” rating and a $20.00 price target on the stock. Jefferies Financial Group increased their price target on shares of Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Finally, New Street Research set a $19.00 price objective on Envista in a report on Thursday, March 6th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat, Envista currently has a consensus rating of “Hold” and an average price target of $20.18.

Envista Stock Down 5.9 %

Shares of NYSE NVST opened at $16.96 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.04 and a quick ratio of 1.76. The firm’s 50-day moving average is $19.59 and its two-hundred day moving average is $19.60. Envista Holdings Co. has a 12-month low of $15.15 and a 12-month high of $23.00. The company has a market capitalization of $2.92 billion, a PE ratio of -2.61, a price-to-earnings-growth ratio of 1.27 and a beta of 1.33.

Envista (NYSE:NVST) last announced its earnings results on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. Equities analysts anticipate that Envista Holdings Co. will post 1 EPS for the current fiscal year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.